FeesSafety
Pluang+

Northeast Bank posts Q1 net income of $29M, declares $0.01 dividend amid strong loan growth.

Company Fundamentals
26 Oct 2026, 23:16 WIB
GlobeNewsWire
View Source
Bullish
Northeast Bank posts Q1 net income of $29M, declares $0.01 dividend amid strong loan growth.

Northeast Bank reported a net income of $29 million for Q1 2027, up from $22.5 million the previous year, driven by strong loan production of $534.3 million and healthy asset quality. The bank's National Lending Division set a record with $258.6 million in originated loans, while total assets rose to $5.35 billion. The Board declared a $0.01 per share dividend payable in November. These results highlight the bank's resilient business model and position it for continued growth.

Northeast Bank's first quarter results and dividend declaration provide context for financial sector activity. For readers following Financials, here is Pluang's market snapshot as of Oct 27, 2026 03:21 WIB: Out of 142 priced Financials-sector US stocks tradable on Pluang, 76 rose and 66 fell today. Notable movers include Banco Bradesco Sa American Depositary Shares (BBD) at USD 2.96 with a 1-day change of -27.27% and Pluang order activity showing 2% Sell / 98% Buy, Itau Unibanco Banco Holding SA American Depositary Shares (ITUB) at USD 7.70 with a 1-day change of -20.42% and 0% Sell / 100% Buy, and Nu Holdings Ltd (NU) at USD 12.60 with a 1-day change of -16.89% and 5% Sell / 95% Buy. The most notable figure is BBD's 27.27% decline in one day.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
1 hour ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
1 hour ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
2 hours ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
3 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App